Accéder directement au contenu Accéder directement à la navigation
Nouvelle interface
Article dans une revue

A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis

Heather E. Olson 1 Nolwenn Jean-Marçais 2, 3 Edward Yang 4 Delphine Héron 5, 5 Katrina Tatton-Brown Paul van Der Zwaag 6 Emilia Bijlsma 7 Bryan Krock 8 E. Backer Erik-Jan Kamsteeg Margje Sinnema Margot R.F. Reijnders David Bearden Amber Begtrup 9 Aida Telegrafi 9 Roelineke Lunsing Lydie Burglen 10, 11 Gaetan Lesca 12, 13 Megan T Cho 9 Lacey Smith Beth Sheidley Christelle Moufawad El Achkar Phillip Pearl 4 Annapurna Poduri Cara Skraban Jennifer Tarpinian Addie I. Nesbitt 14 Dietje Fransen van de Putte Claudia A.L. Ruivenkamp 15 Patrick Rump Nicolas Chatron 13, 12 Isabelle Sabatier 16 Julitta de Bellescize 17 Laurent Guibaud 18 David Sweetser Jessica Waxler Klaas Wierenga - Ddd Study Jean Donadieu 19 Vinodh Narayanan Keri Ramsey - C4rcd Research Group Caroline Nava 5, 20 Jean-Baptiste Rivière 21, 3 Antonio Vitobello 21, 3 Frederic Tran Mau-Them 21, 3 Christophe Philippe 21, 3 Ange-Line Bruel 21, 3 Yannis Duffourd 3, 21 Laurel Thomas 22 Stefan H. Lelieveld 23, 24 Janneke Schuurs-Hoeijmakers 23 Han G. Brunner 23, 25 Boris Keren 5, 20 Julien Thevenon 2, 3, 21 Laurence Faivre 2, 3, 21 Gary Thomas 26 Christel Thauvin-Robinet 2, 3, 21, * 
* Auteur correspondant
21 Equipe GAD (LNC - U1231)
LNC - Lipides - Nutrition - Cancer [Dijon - U1231]
Abstract : Developmental and epileptic encephalopathies (DEEs) represent a large clinical and genetic heterogeneous group of neurodevelopmental diseases. The identification of pathogenic genetic variants in DEEs remains crucial for deciphering this complex group and for accurately caring for affected individuals (clinical diagnosis, genetic counseling, impacting medical, precision therapy, clinical trials, etc.). Whole-exome sequencing and intensive data sharing identified a recurrent de novo PACS2 heterozygous missense variant in 14 unrelated individuals. Their phenotype was characterized by epilepsy, global developmental delay with or without autism, common cerebellar dysgenesis, and facial dysmorphism. Mixed focal and generalized epilepsy occurred in the neonatal period, controlled with difficulty in the first year, but many improved in early childhood. PACS2 is an important PACS1 paralog and encodes a multifunctional sorting protein involved in nuclear gene expression and pathway traffic regulation. Both proteins harbor cargo(furin)-binding regions (FBRs) that bind cargo proteins, sorting adaptors, and cellular kinase. Compared to the defined PACS1 recurrent variant series, individuals with PACS2 variant have more consistently neonatal/early-infantile-onset epilepsy that can be challenging to control. Cerebellar abnormalities may be similar but PACS2 individuals exhibit a pattern of clear dysgenesis ranging from mild to severe. Functional studies demonstrated that the PACS2 recurrent variant reduces the ability of the predicted autoregulatory domain to modulate the interaction between the PACS2 FBR and client proteins, which may disturb cellular function. These findings support the causality of this recurrent de novo PACS2 heterozygous missense in DEEs with facial dysmorphim and cerebellar dysgenesis.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : LNC - université de Bourgogne Connectez-vous pour contacter le contributeur
Soumis le : mardi 12 mars 2019 - 11:56:06
Dernière modification le : jeudi 1 décembre 2022 - 14:02:08

Lien texte intégral



Heather E. Olson, Nolwenn Jean-Marçais, Edward Yang, Delphine Héron, Katrina Tatton-Brown, et al.. A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. American Journal of Human Genetics, 2018, 102 (5), pp.995-1007. ⟨10.1016/j.ajhg.2018.03.005⟩. ⟨hal-02064909⟩



Consultations de la notice